Get access

Optimal timing for discontinuation of Pneumocystis jiroveci pneumonia prophylaxis in adult patients on highly active antiretroviral therapy (HAART) for HIV infection

  • Protocol
  • Intervention



This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the impact of discontinuation of Pneumocystis jiroveci prophylaxis on the morbidity and mortality due to Pneumocystis jiroveci pneumonia in HIV patients who show a stable rise in CD4 counts to >200cells/mm3for three or more months following initiation of HAART.